When the hope goes: Talking with patients after withdrawal from cancer clinical trials
Cancer clinical trials remain underutilized by patients as a means of acquiring experimental drugs, tests and/or procedures that they otherwise might not be able to obtain. Connie Ulrich spoke to Healio about why people withdraw from clinical trials.
The Relationship between Health and Place: Expanding Use of Place-Based Disadvantage Indices Beyond COVID-19
While disadvantage indices are increasingly recognized as a valuable tool to help promote health and prioritize equity, future use of these tools must include investments in data infrastructure, community partnerships, and further evaluation. Harald Schmidt provides insight.
Why Schools Are Offering Money, and More, to Get Kids Vaccinated
Emily Largent speaks to TIME about vaccine incentives offered by schools hoping to encourage COVID-19 vaccination.
FDA authorizes Pfizer-BioNTech vaccine for children 5 to 11
On Friday, October 29, regulators authorized the Pfizer coronavirus vaccine for children 5 to 11 years old. A watershed moment celebrated by parents yearning for a return to normal life but viewed with ambivalence and outright skepticism by others worried about the potential risk of unknown side effects.
Virtual lecture with Susan Neiman: What I Learned After Writing 'Learning From the Germans'
The 36th Annual Joseph Alexander Colloquium in the Jewish Studies Program invites you to attend this lecture on confronting race and the memory of evil.
The US Should Change Payment To Make Health Care More Equitable
Medicare, Medicaid, and private payers have spent the better part of a decade reforming health care payment to emphasize value rather than the volume of care. But despite the benefits of these reforms, newer value-based payment approaches have not addressed deep-seated health inequities facing many Americans.
Raina Merchant receives Penn Medicine Award of Excellence
Raina Merchant is a recipient of one of the 2021 Penn Medicine Awards of Excellence
Emily Largent & Holly Fernandez Lynch have a new paper in JAMA Internal Medicine
"When patients have a diagnosis of desperation that leaves them facing a life-limiting disease without good treatment options, what role should their willingness to try a drug of unproven benefit play in regulatory decision-making?"
New paper from Holly Fernandez Lynch aims to address patients’ questions about treatment for non-COVID-19 diseases
Patients have legitimate questions surrounding treatment plans for non-COVID illnesses. If so much could move so fast to treat COVID-19, why can’t other treatments receive the same approval/access?
Atheendar Venkataramani co-leads new almost $10M NIH grant
The grant funds research to investigate the impact of neighborhood place-based and financial well-being interventions, targeting the root causes of structural racism that contribute to poor health in Black communities.
Our Faculty & Fellows to Present at 2021 American Society for Bioethics and Humanities (ASBH) Annual Conference
Several members of the Department of Medical Ethics & Health Policy will be presenting at the 2021 American Society for Bioethics and Humanities (ASBH) Annual Conference. Running from October 11...
How Government Data Is Being Misused to Question COVID-19 Vaccine Safety
Unverified reports linking the vaccine to deaths have been circulating on social and mainstream media for months
National Academy of Medicine Recognizes Dr. Roberto as a 2021 Emerging Leader in Health and Medicine Scholar
The National Academy of Medicine (NAM) has recognized Christina Roberto, PhD, as one of 10 Emerging Leaders in Health and Medicine Scholars.
Biden Promised to Follow the Science. But Sometimes, He Gets Ahead of the Experts.
White House officials dismiss criticism that President Biden’s comments on booster shots amount to undue pressure on public health experts.
Dr. Jennifer J. Prah Named Director of the Ortner Center on Violence and Abuse
"I look forward to collaborating with faculty, staff and students to build on the critical mission and remarkable legacy of the Ortner Center to investigate the correlates and consequences of violence, abuse and control against women and girls as well as the conditions for women and girls to be healthy and flourish,” Dr. Prah said.
'Locker Room' Talk About Death: Time for Oncologists to Stop
Death is a routine, inevitable part of an oncologist's life, and over time, oncology training and practice hardens us to it.
NASEM Report on Behavioral, Social Science Research Questions Raised by the Use of Biomarkers for Pre-Clinical Alzheimer's
In June, the National Academies of Sciences, Engineering, and Medicine convened an expert meeting that addressed behavioral and social science research questions raised by the use of biomarkers and other measures (e.g., digital/sensor data) for pre-clinical AD/ADRD diagnosis.
Dr. Risa Lavizzo-Mourey wins Gustav O. Lienhard Award for Advancement of Health Care from National Academy of Medicine
This award recognizes individuals for outstanding achievement in improving health care services in the United States.
Pa. doctor offering free mask-exemption letter for parents faces possible discipline
Joel Yeager, whose practice is in Lebanon County, has since removed the form from his website. The state said it was referring such cases to the appropriate boards for potential disciplinary action.